Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2190-3948
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Characterization of a liposomal copper(II)-quercetin formulation suitable for parenteral use ; day:3 ; month:9 ; year:2019 ; pages:1-14
Drug Delivery and Translational Research ; (3.9.2019), 1-14
- Urheber
-
Chen, Kent T. J.
Anantha, Malathi
Leung, Ada W. Y.
Kulkarni, Jayesh A.
Militao, Gardenia G. C.
Wehbe, Mohamed
Sutherland, Brent
Cullis, Pieter R.
Bally, Marcel B.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s13346-019-00674-7
- URN
-
urn:nbn:de:101:1-2020011607005029745898
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chen, Kent T. J.
- Anantha, Malathi
- Leung, Ada W. Y.
- Kulkarni, Jayesh A.
- Militao, Gardenia G. C.
- Wehbe, Mohamed
- Sutherland, Brent
- Cullis, Pieter R.
- Bally, Marcel B.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development and characterization of liposomal formulation of bortezomib
Oil-based parenteral depot formulation for veterinary peptide delivery
Effect of liposomal formulation of ascorbic acid on corneal permeability
UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
Publisher Correction: The influence of liposomal quercetin on liver damage induced by microwave ablation
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Development of a copper-clioquinol formulation suitable for intravenous use
A nano-Liposomal formulation potentiates antioxidant, anti-inflammatory, and fibrinolytic activities of Allolobophora caliginosa coelomic fluid: formulation and characterization
Development and characterization of liposomal formulation of bortezomib
Oil-based parenteral depot formulation for veterinary peptide delivery
Effect of liposomal formulation of ascorbic acid on corneal permeability
UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
Publisher Correction: The influence of liposomal quercetin on liver damage induced by microwave ablation
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Development of a copper-clioquinol formulation suitable for intravenous use
A nano-Liposomal formulation potentiates antioxidant, anti-inflammatory, and fibrinolytic activities of Allolobophora caliginosa coelomic fluid: formulation and characterization
Development and characterization of liposomal formulation of bortezomib
Oil-based parenteral depot formulation for veterinary peptide delivery
Effect of liposomal formulation of ascorbic acid on corneal permeability
UPLC-MS/MS quantification of quercetin in plasma and urine following parenteral administration
Publisher Correction: The influence of liposomal quercetin on liver damage induced by microwave ablation
Transformation of dolutegravir into an ultra-long-acting parenteral prodrug formulation
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Formulation and process development of biodegradable microparticles for controlled parenteral drug delivery
Addressing bottlenecks in Lassa fever treatment: overcoming the ribavirin parenteral formulation challenge
Formulation development of biodegradable implants for extended parenteral delivery of protein drugs
Development of a copper-clioquinol formulation suitable for intravenous use